98%
921
2 minutes
20
Background: Endometriosis (EMS) is characterized by the occurrence, growth, infiltration, and recurrent bleeding of endometrial tissue outside the uterus. Recent studies have revealed a close association between Neutrophil Extracellular Traps (NETs) and the proliferation and metastasis of tumors. As EMS and tumours have similar biological behaviours, we hypothesised that key factors in tumourigenesis may also significantly influence the pathogenesis of EMS. Therefore, this study aimed to explore the potential link that exists between NETs and endometriosis.
Methods: A total of 190 patients were selected and divided into control and endometriosis groups (95 patients each) based on inclusion and exclusion criteria. Samples from ectopic and eutopic endometrium in the experimental group, eutopic endometrium in the control group, and peripheral blood serum and neutrophils (PMN) were collected and analyzed. ROC curve analysis was used to evaluate the diagnostic ability of NETs-associated markers to differentiate endometriosis patients from controls.
Results: The analysis of both patient groups revealed that levels of circulating free DNA (cf-DNA), nucleosomes, and neutrophil elastase (NE) were significantly higher in the experimental group compared to the controls. Further analysis indicated that the levels of NETs-related factors were elevated in patients with infertility and there was a positive correlation between pain severity and NETs markers in patients experiencing pain. Additionally, the ROC curve analysis demonstrated significant differences in cf-DNA, nucleosomes, and NE levels between the experimental and control groups (P < 0.05).
Conclusion: NETs-associated markers may be linked to endometriosis, likely due to their involvement in tumor proliferation and metastasis, which share similarities with endometriosis. Further studies are needed to explore the mechanisms connecting endometriosis and NETs markers.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12277182 | PMC |
http://dx.doi.org/10.2147/IJWH.S504327 | DOI Listing |
Virchows Arch
September 2025
Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais, Minas Gerais, Av. Antônio Carlos, Pampulha, Belo Horizonte, 31270-901, Brazil.
Plasmablastic lymphoma (PBL) is a rare and aggressive non-Hodgkin lymphoma with a poor prognosis and short survival rates. It is classified as a large B-cell lymphoma subtype, but carries a plasmacytic immunophenotype. Therefore, PBL has pathogenetic overlaps with diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS) and plasma cell neoplasms (PCNs).
View Article and Find Full Text PDFImmunity
September 2025
Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria. Electronic address:
In a recent issue of Nature, Adrover et al. report a neutrophil subset that induces pleomorphic tumor necrosis through neutrophil extracellular trap (NET)-mediated vascular occlusion. This process drives epithelial-to-mesenchymal transition (EMT) and metastasis of perinecrotic cancer cells, reframing necrosis as an active process and uncovering targetable mechanisms to combat cancer dissemination.
View Article and Find Full Text PDFAm J Physiol Cell Physiol
September 2025
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC.
Cachexia, the loss of skeletal muscle mass and function with cancer, contributes to reduced life quality and worsened survival. Skeletal muscle fibrosis leads to disproportionate muscle weakness; however, the role of infiltrating immune cells and fibro-adipogenic progenitors (FAPs) in cancer-induced muscle fibrosis is not well understood. Using the C26 model of cancer cachexia, we sought to examine the changes to skeletal muscle immune cells and FAPs which contribute to excessive extracellular matrix (ECM) collagen deposition.
View Article and Find Full Text PDFPLoS One
September 2025
Department of Cardiac Surgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Background: Cardiac ischemia reperfusion (I/R) injury is a serious consequence of reperfusion therapy for myocardial infarction (MI). Peptidylarginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the citrullination of proteins. In previous studies, PAD4 inhibition protected distinct organs from I/R injury by preventing the formation of neutrophil extracellular traps (NETs) and attenuating inflammatory responses.
View Article and Find Full Text PDFFront Immunol
September 2025
Institute of Pulmonary Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Neutrophil extracellular traps (NETs) are DNA-protein structures released during a form of programmed neutrophil death known as NETosis. While NETs have been implicated in both tumor inhibition and promotion, their functional role in cancer remains ambiguous. In this study, we compared the NET-forming capacity and functional effects of NETs derived from lung cancer (LC) patients and healthy donors (H).
View Article and Find Full Text PDF